Skip to main content

Organon & Co.

For the period ended Jun 30, 2024. Filed Aug 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 7, 2024

OGN$13.89+0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Income

(Unaudited, $ in millions except shares in thousands and per share amounts)

Three Months EndedJune 30,Six Months EndedJune 30,
2024202320242023
Revenues$1,607$1,608$3,229$3,146
Cost of sales6686401,3331,220
Gross profit9399681,8961,926
Selling, general and administrative437451868886
Research and development116128228257
Acquired in-process research and development and milestones15—308
Restructuring costs——234
Interest expense131132262264
Exchange (gains) losses(1)2511
Other expense, net6197
Income before income taxes235254471489
Taxes on income40127570
Net income$195$242$396$419
Earnings per share:
Basic$0.76$0.95$1.54$1.64
Diluted$0.75$0.95$1.53$1.64
Weighted average shares outstanding:
Basic257,288255,341256,492254,869
Diluted258,598255,953258,480256,064

-3-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.